Update on the treatment of Behçet's syndrome
SN Esatoglu, G Hatemi - Internal and Emergency Medicine, 2019 - Springer
Behçet's syndrome (BS) is a complex disease that shows important heterogeneity in clinical
findings and physiopathology. Its treatment can be problematic as BS manifestations in …
findings and physiopathology. Its treatment can be problematic as BS manifestations in …
Advances in the treatment of Behcet's disease
F Alibaz-Oner, H Direskeneli - Current rheumatology reports, 2021 - Springer
Abstract Purpose of Review To assess current management of Behcet's disease (BD).
Controversies on therapeutic approaches to different manifestations, whether conventional …
Controversies on therapeutic approaches to different manifestations, whether conventional …
Management of Behçet's syndrome
Management of Behçet's syndrome : Current Opinion in Rheumatology Management of Behçet's
syndrome : Current Opinion in Rheumatology Log in or Register Subscribe to journalSubscribe …
syndrome : Current Opinion in Rheumatology Log in or Register Subscribe to journalSubscribe …
New therapeutic solutions for Behçet's syndrome
Introduction: Behçet's syndrome (BS) is a systemic inflammatory disorder characterized by a
wide range of potential clinical manifestations with no gold-standard therapy. However, the …
wide range of potential clinical manifestations with no gold-standard therapy. However, the …
Behcet's syndrome
SR Dalvi, R Yildirim, Y Yazici - Drugs, 2012 - Springer
Behcet's syndrome (BS) is a vasculitis, seen more commonly around the Mediterranean and
the Far East, and manifests with oral and genital ulcerations, skin lesions, uveitis, and …
the Far East, and manifests with oral and genital ulcerations, skin lesions, uveitis, and …
Standard and novel therapeutic approaches to Behçet's disease
A Gul - Drugs, 2007 - Springer
Behçet's disease (BD), a systemic inflammatory disorder of unknown aetiology, is
characterised by recurrent attacks of oral aphthous ulcers, genital ulcers, skin lesions, uveitis …
characterised by recurrent attacks of oral aphthous ulcers, genital ulcers, skin lesions, uveitis …
Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients
A Arida, K Fragiadaki, E Giavri, PP Sfikakis - Seminars in arthritis and …, 2011 - Elsevier
OBJECTIVE:: Off-label use of anti-tumor necrosis factor (TNF) agents for Behçet's disease
(BD) is increasing. We evaluated published data on their efficacy and safety for patients with …
(BD) is increasing. We evaluated published data on their efficacy and safety for patients with …
A contemporary review of behcet's syndrome
J Chen, X Yao - Clinical reviews in allergy & immunology, 2021 - Springer
Behcet's syndrome (BS) is a chronic systemic inflammatory vasculitis with a wide range of
clinical manifestations including recurrent oral and genital ulcers; cutaneous lesions; and …
clinical manifestations including recurrent oral and genital ulcers; cutaneous lesions; and …
Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: efficacy, safety, and pharmacokinetics in a multicenter, prospective, open …
T Hibi, S Hirohata, H Kikuchi, U Tateishi, N Sato… - Medicine, 2016 - journals.lww.com
Behçet disease (BD) is a multisystem disease associated with a poor prognosis in cases of
gastrointestinal, neurological, or vascular involvement. We conducted a multicenter …
gastrointestinal, neurological, or vascular involvement. We conducted a multicenter …